Now, while it is simple to snicker with the ridiculousness of the patent, poor patents have major implications for the entire psychedelics market.“NeonMind’s proprietary preclinical information displays promise that each low and large dose psilocybin might lessen body weight obtain and which the reduction in bodyweight attain can take place in